Developing predictive molecular maps of human disease through community-based modeling
- PMID: 22281773
- PMCID: PMC3643818
- DOI: 10.1038/ng.1089
Developing predictive molecular maps of human disease through community-based modeling
Abstract
The inability to identify the molecular causes of disease has led to a disappointing rate of development of new medicines. By combining the power of community-based modeling with broad access to large datasets on a platform that promotes reproducible analyses, we can work toward more predictive molecular maps that can deliver better therapeutics.
Conflict of interest statement
The authors declare no competing financial interests.
Figures


References
-
- Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates. Nat Rev Drug Discov. 2004;3:711–715. - PubMed
-
- Barabási AL, Oltvai ZN. Network biology: understanding the cell’s functional organization. Nat Rev Genet. 2004;5:101–113. - PubMed
-
- Friend SH. The need for precompetitive integrative bionetwork disease model building. Clin Pharmacol Ther. 2010;87:536–539. - PubMed
-
- Schadt EE, Friend SH, Shaywitz DA. A network view of disease and compound screening. Nat Rev Drug Discov. 2009;8:286–295. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources